New blood test to guide antibiotic use in newborns
Part of Genetic & congenital, Infections clinical trials.
This study is testing a new blood test to see if it can help doctors decide when to use antibiotics for newborns who may have a late-onset infection. The goal is to reduce unnecessary antibiotic use.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your baby must be in the neonatal intensive care unit (NICU).
- Your baby must be at least 7 days old.
- Your baby must weigh at least 500 grams (about 1.1 pounds).
- Your baby must have signs of a possible late-onset infection (like fever, breathing problems, or skin changes).
- Your baby must not be on antibiotics for a confirmed infection right now or in the past 48 hours.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study checks if a blood test (presepsin) can help doctors safely stop antibiotics earlier in preterm babies at moderate risk of infection. The goal is to reduce unnecessary antibiotic use.
This trial tests a new, faster way to find bacteria in the blood of children with suspected sepsis. It uses a molecular test that may give results sooner than standard cultures, helping doctors treat infections more quickly.
This study looks at two simple blood tests (CBC and lactate) in newborns with signs of infection. These tests may help doctors find sepsis faster and guide treatment.
This trial is testing ways to make the best treatment decisions for newborns who may have an early infection (sepsis). It focuses on babies born at 34 weeks or later and within their first three days of life.
This study looks at a new way to decide if a newborn might have an infection and needs treatment. It may help avoid unnecessary treatments for babies who are not really infected.
This study tests a new blood marker (called MDW) to help doctors quickly spot late-onset sepsis in preterm babies. If it works, it could lead to faster treatment for infections in premature infants.
Hear when a new Neonatal Late Onset Sepsis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.